Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
The following ETFs maintain exposure to MoonLake Immunotherapeutics (MLTX). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
34 ETFs Hold MoonLake Immunotherapeutics (MLTX)
Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in MLTX |
|---|---|---|---|---|---|---|
| ALPS Medical Breakthroughs ETF | $99.19M | 0.50% | 2.19% | $2.17M | 0.08% | |
| Global X Guru Index ETF | $49.09M | 0.75% | 1.36% | $676.02K | 0.02% | |
| AdvisorShares Dorsey Wright Micro-Cap ETF | $2.32M | 1.25% | 1.29% | $30.40K | <0.01% | |
| HANetf ICAV - HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF Accum-USD- | $13.83M | 0.59% | 1.00% | $137.78K | <0.01% | |
| Fidelity Disruptive Medicine ETF | $55.02M | 0.50% | 0.92% | $505.76K | 0.02% | |
| Harbor Health Care ETF | $15.95M | 0.80% | 0.84% | $133.26K | <0.01% | |
| Virtus LifeSci Biotech Clinical Trials ETF | $6.56M | 0.79% | 0.75% | $49.27K | <0.01% | |
| Goldman Sachs Future Health Care Equity ETF | $20.99M | 0.75% | 0.47% | $99.89K | <0.01% | |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF | $521.86M | 0.57% | 0.31% | $1.80M | 0.06% | |
| First Trust IPOX Europe Equity Opportunities ETF | $3.89M | 0.70% | 0.11% | $4.88K | <0.01% |
